simotinib
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2011 (NCT01469910)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
EGFR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- simotinib hydrochloride
- simotinib hydrochloride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01772732 | Phase 1 | Dec 1, 2012 | Chinese Academy of Medical Sciences, Simcere Pharmaceutical Co., Ltd |
| NCT01469910 | Phase 1 | Sep 1, 2011 | Central South University, Simcere Pharmaceutical Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Simcere Pharmaceutical Co., Ltd | For profit | 2 | 2 | 1 | 2011 |
| Central South University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1